鼻子的主导作用增强了鼻内催产素的抗焦虑作用
Nikita Catalina Julius1, Dasha Nicholls1, Joseph Nowell1
1Division of Psychiatry, Department of Brain Sciences, Imperial College London, Du Cane Road, W12 0NN, London, UK.
Scientific reports
|May 27, 2025
概括
鼻内催产素可以降低青少年女性的压力. 输送到主导鼻孔可以增强催产素的作用.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
背景情况:
- 鼻子循环描述了鼻孔之间的交替空气流.
- 鼻内催产素已知具有潜在的抗焦虑作用.
研究的目的:
- 调查鼻腔主导是否影响鼻内催产素的减压作用.
- 为了确定最佳的鼻孔用于鼻内催产素的输送.
主要方法:
- 一项涉及44名女性青少年 (16-17岁) 的探索性研究.
- 通过向主导与非主导鼻孔输送的催产素减少压力的比较,与安慰剂相比.
主要成果:
- 与安慰剂相比,鼻内催产素显著降低了压力 (p=0.012).
- 当催产素被输送到主导鼻孔时,观察到更大的压力减轻 (p=0.034).
结论:
- 通过主导鼻孔给药催产素可以优化压力减轻和焦虑溶解.
- 需要进一步研究心理药物的鼻孔特异性影响.
相关概念视频
Neurotransmitters
1.5K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
1.5K
Adrenergic Agonists: Direct-Acting Agents
1.8K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.8K
Olfactory Receptors: Location and Structure
9.7K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
9.7K
Drug-Receptor Interaction: Agonist
2.9K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.9K
Adrenergic Agonists: Therapeutic Uses
996
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
996
Adrenergic Agonists: Mixed-Action Agents
911
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
911


